US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Protalix BioTherapeutics

1.72

-1.1700-40.48%

Post-market: 1.770.0498+2.90%19:58 EDT

Volume:5.95M

Turnover:11.29M

Market Cap:134.22M

PE:46.93

High:2.39

Open:2.39

Low:1.72

Close:2.89

Loading ...

Overview Company News Filings

Protalix BioTherapeutics Earnings Call: Growth Amid Challenges

Protalix BioTherapeutics Q1 EPS $(0.05) Misses $0.03 Estimate, Sales $10.11M Miss $21.60M Estimate

Press Release: Protalix BioTherapeutics Reports First Quarter 2025 Financial and Business Results

PLUXEE N.V. (PLX) Receives a Buy from Citi

Protalix BioTherapeutics to Announce First Quarter 2025 Financial and Business Results on May 9, 2025

Protalix files $100M mixed securities shelf

Top Penny Stocks To Watch In April 2025

Simply Wall St.

Kepler Capital Sticks to Its Buy Rating for PLUXEE N.V. (PLX)

Protalix BioTherapeutics' CFO Rubin to Leave

UBS Reaffirms Their Hold Rating on PLUXEE N.V. (PLX)

PLUXEE N.V. (PLX) Gets a Hold from Barclays

Protalix BioTherapeutics And 2 Other Promising Penny Stocks

Simply Wall St.

Protalix BioTherapeutics to Present at the iAccess Alpha Virtual Best Ideas Spring Conference 2025

Is Protalix BioTherapeutics (PLX) The High Growth Low Debt Stock to Invest in Now?

PLX: 2024 Results

Zacks Small Cap Research

Protalix BioTherapeutics Reports Record Revenue and Clinical Progress

Protalix BioTherapeutics Says With Debt Fully Repaid, It's Well-Positioned To Execute Strategy Through 2025 And Beyond

Protalix BioTherapeutics FY 2024 GAAP EPS $0.04 Beats $0.01 Estimate, Sales $53.40M Miss $53.94M Estimate

Press Release: Protalix BioTherapeutics Reports Fiscal Year 2024 Financial and Business Results

Protalix BioTherapeutics to Announce Fiscal Year 2024 Financial and Business Results on March 17, 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PLX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PLX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PLX\",,,,,undefined,":{"symbol":"PLX","market":"US","secType":"STK","nameCN":"Protalix BioTherapeutics","latestPrice":1.72,"timestamp":1746820800000,"preClose":2.89,"halted":0,"volume":5949694,"hourTrading":{"tag":"盘后","latestPrice":1.7698,"preClose":1.72,"latestTime":"19:58 EDT","volume":7424,"amount":13057.1549,"timestamp":1746835086140},"delay":0,"floatShares":59149635,"shares":78032585,"eps":0.036653,"marketStatus":"Market Closed","change":-1.17,"latestTime":"05-09 16:00:00 EDT","open":2.39,"high":2.39,"low":1.72,"amount":11290966.341866,"amplitude":0.231834,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.036653,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":829022400000,"exchange":"AMEX","adjPreClose":2.89,"preHourTrading":{"tag":"盘前","latestPrice":2.02,"preClose":2.89,"latestTime":"09:29 EDT","volume":161241,"amount":358997.523686,"timestamp":1746797399999},"postHourTrading":{"tag":"盘后","latestPrice":1.7698,"preClose":1.72,"latestTime":"19:58 EDT","volume":7424,"amount":13057.1549,"timestamp":1746835086140},"volumeRatio":7.412974731664742,"impliedVol":1.5854,"impliedVolPercentile":0.764},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PLX\",,,,,undefined,":{"symbol":"PLX","floatShares":59149635,"roa":"3.10%","roe":"7.64%","lyrEps":0.040424,"volumeRatio":7.412974731664742,"shares":78032585,"dividePrice":0,"high":2.39,"amplitude":0.231834,"preClose":2.89,"low":1.72,"week52Low":0.8214,"pbRate":"3.11","psRate":"2.51","week52High":3.1,"institutionHeld":0.0443,"latestPrice":1.72,"eps":0.036653,"divideRate":0,"volume":5949694,"delay":0,"ttmEps":0.036653,"open":2.39,"prevYearClose":1.88,"prevWeekClose":3,"prevMonthClose":3.07,"prevQuarterClose":2.56,"fiveDayClose":3,"twentyDayClose":2.31,"sixtyDayClose":2.67},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PLX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2534968634","title":"Protalix BioTherapeutics Earnings Call: Growth Amid Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2534968634","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534968634?lang=en_us&edition=fundamental","pubTime":"2025-05-10 09:12","pubTimestamp":1746839536,"startTime":"0","endTime":"0","summary":"Protalix Biotherapeutics (($PLX)) has held its Q1 earnings call. Read on for the main highlights of the call. The recent earnings call for Protalix...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/protalix-biotherapeutics-earnings-call-growth-amid-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/protalix-biotherapeutics-earnings-call-growth-amid-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLX"],"gpt_icon":0},{"id":"2534104388","title":"Protalix BioTherapeutics Q1 EPS $(0.05) Misses $0.03 Estimate, Sales $10.11M Miss $21.60M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2534104388","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534104388?lang=en_us&edition=fundamental","pubTime":"2025-05-09 18:53","pubTimestamp":1746788003,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics (AMEX:PLX) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $0.03 by 266.67 percent. This is a 16.67 percent increase over losses of $(0.06) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45313466/protalix-biotherapeutics-q1-eps-0-05-misses-0-03-estimate-sales-10-11m-miss-21-60m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX"],"gpt_icon":0},{"id":"2534892104","title":"Press Release: Protalix BioTherapeutics Reports First Quarter 2025 Financial and Business Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2534892104","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534892104?lang=en_us&edition=fundamental","pubTime":"2025-05-09 18:50","pubTimestamp":1746787800,"startTime":"0","endTime":"0","summary":"Company to host conference call and webcast today at 8:30 a.m. EDT. CARMIEL, Israel, May 9, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. , a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx plant cell-based protein expression system, today reported financial results for the quarter ended March 31, 2025, and provided a business and clinical update.\"We had another solid quarter, with an increase in revenues from selling goods compared to the prior year quarter,\" said Dror Bashan, Protalix's President and Chief Executive Officer. \"Given the promising results obtained in 2024 from our first-in-human study of our gout candidate, PRX-115, we are focused on building on the momentum and working toward initiating a phase II clinical trial in patients with gout later this year. At the same time, we continued to evaluate additional pipeline candidates for potential further develo","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002232.USD","IE000M9KFDE8.USD","ACR","LU0868494617.USD","LU1894683264.USD","BK4232","IE00BLSP4239.USD","SGXZ57979304.SGD","BK4099","IE00BLSP4452.SGD","LU0321505439.SGD","BK4568","LU1057294990.SGD","BK4534","IE00B19Z3581.USD","SG9999002224.SGD","BK4599","LU0289739699.SGD","PLX","LU0985481810.HKD","SG9999011175.SGD","SG9999013999.USD","LU0170899867.USD","LU0321505868.SGD","BK4218","IE00B19Z3B42.SGD","BK4588","BK4585","LU0122379950.USD","LU0306807586.USD","R","TM","LU1883839398.USD","BK4581","LU1023059063.AUD","IE00BBT3K403.USD","PK","03160","SG9999001176.SGD","BK4555","LU0225284248.USD","LU1066053197.SGD","LU1066051498.USD","BK4604","BK4022","SG9999003800.SGD","SG9999001176.USD","LU0225771236.USD","LU1894683348.USD"],"gpt_icon":1},{"id":"2533544164","title":"PLUXEE N.V. (PLX) Receives a Buy from Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2533544164","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533544164?lang=en_us&edition=fundamental","pubTime":"2025-05-06 13:35","pubTimestamp":1746509748,"startTime":"0","endTime":"0","summary":"In a report released today, Pavan Daswani from Citi maintained a Buy rating on PLUXEE N.V. (PLX – Research Report), with a price target of €38.00. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/pluxee-n-v-plx-receives-a-buy-from-citi?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/pluxee-n-v-plx-receives-a-buy-from-citi?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2533708588","title":"Protalix BioTherapeutics to Announce First Quarter 2025 Financial and Business Results on May 9, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2533708588","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533708588?lang=en_us&edition=fundamental","pubTime":"2025-05-05 18:50","pubTimestamp":1746442200,"startTime":"0","endTime":"0","summary":"Company to host conference call and webcast at 8:30 a.m. EDT. CARMIEL, Israel, May 5, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. , a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx plant cell–based protein expression system, today announced that it will release its financial results for the quarter ended March31, 2025 and provide a business and clinical update on May9, 2025.Management will host a conference call to discuss the financial results and provide an update on recent corporate and regulatory developments.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/protalix-biotherapeutics-announce-first-quarter-105000306.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/protalix-biotherapeutics-announce-first-quarter-105000306.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2531126450","title":"Protalix files $100M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2531126450","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531126450?lang=en_us&edition=fundamental","pubTime":"2025-04-29 05:05","pubTimestamp":1745874349,"startTime":"0","endTime":"0","summary":"17:01 EDT Protalix (PLX) files $100M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/protalix-files-100m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/protalix-files-100m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2530966470","title":"Top Penny Stocks To Watch In April 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2530966470","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530966470?lang=en_us&edition=fundamental","pubTime":"2025-04-25 02:05","pubTimestamp":1745517911,"startTime":"0","endTime":"0","summary":"As the U.S. stock market experiences a surge, driven by positive earnings reports and anticipation of tariff news, investors are paying close attention to potential opportunities across various sectors. For those willing to explore beyond established giants, penny stocks—often representing smaller or newer companies—remain an intriguing option. Despite being considered somewhat outdated, these stocks can still offer significant growth potential when backed by strong financials and sound fundamentals. In this article, we highlight three penny stocks that stand out for their balance sheet strength and potential for impressive returns.Overview: Origin Materials, Inc. operates as a carbon-negative materials company with a market cap of $102.24 million.Click here and access our complete financial health analysis report to understand the dynamics of Origin Materials.Gain insights into Origin Materials' outlook and expected performance with our report on the company's earnings estimates.Overv","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/top-penny-stocks-watch-april-180511198.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4563","SB","BK4509","BK4023","BABB","BK4179","BK4209","ORGN","BK4526","SGMT","BK4505","BK4139","TTI","PLX","BK4090","ORGNW","TUYA","BK4021"],"gpt_icon":0},{"id":"2529613563","title":"Kepler Capital  Sticks to Its Buy Rating for PLUXEE N.V. (PLX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2529613563","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529613563?lang=en_us&edition=fundamental","pubTime":"2025-04-24 09:48","pubTimestamp":1745459302,"startTime":"0","endTime":"0","summary":"Kepler Capital analyst Julien Richer maintained a Buy rating on PLUXEE N.V. (PLX – Research Report) on April 22. The company’s shares closed yester...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/kepler-capital-sticks-to-its-buy-rating-for-pluxee-n-v-plx-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/kepler-capital-sticks-to-its-buy-rating-for-pluxee-n-v-plx-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLX"],"gpt_icon":0},{"id":"2529566406","title":"Protalix BioTherapeutics' CFO Rubin to Leave","url":"https://stock-news.laohu8.com/highlight/detail?id=2529566406","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529566406?lang=en_us&edition=fundamental","pubTime":"2025-04-24 06:14","pubTimestamp":1745446440,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics' Chief Financial Officer Eyal Rubin plans to leave the company and has given his six months notice.Rubin is leaving to pursue other opportunities, Protalix said Wednesday.The biopharmaceutical said Rubin has been CFO since 2019, and before that worked at BrainStorm Cell Therapeutics and Teva Pharmaceutical Industries.During the six month period, Rubin will continue to serve in his current role and provide transition services to Protalix.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX","BK4139"],"gpt_icon":0},{"id":"2529521953","title":"UBS Reaffirms Their Hold Rating on PLUXEE N.V. (PLX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2529521953","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529521953?lang=en_us&edition=fundamental","pubTime":"2025-04-23 16:26","pubTimestamp":1745396795,"startTime":"0","endTime":"0","summary":"UBS analyst Justin Forsythe maintained a Hold rating on PLUXEE N.V. (PLX – Research Report) today and set a price target of €23.00. The company’s s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ubs-reaffirms-their-hold-rating-on-pluxee-n-v-plx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ubs-reaffirms-their-hold-rating-on-pluxee-n-v-plx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLX"],"gpt_icon":0},{"id":"2529121413","title":"PLUXEE N.V. (PLX) Gets a Hold from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2529121413","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529121413?lang=en_us&edition=fundamental","pubTime":"2025-04-22 14:35","pubTimestamp":1745303753,"startTime":"0","endTime":"0","summary":"Barclays analyst Pravin Gondhale maintained a Hold rating on PLUXEE N.V. (PLX – Research Report) today and set a price target of €26.00. The compan...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/pluxee-n-v-plx-gets-a-hold-from-barclays-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/pluxee-n-v-plx-gets-a-hold-from-barclays-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2522787554","title":"Protalix BioTherapeutics And 2 Other Promising Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2522787554","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522787554?lang=en_us&edition=fundamental","pubTime":"2025-03-26 19:05","pubTimestamp":1742987103,"startTime":"0","endTime":"0","summary":"As U.S. stock markets continue to recover, with major indices closing higher for the third consecutive day, investors are cautiously optimistic about the potential easing of tariffs and its impact on economic growth. In such a climate, identifying promising investment opportunities requires a keen eye for companies that combine financial resilience with growth potential. Though penny stocks might seem like a thing of the past, they still offer significant opportunities when backed by solid fundamentals. This article will explore three such penny stocks that stand out for their financial strength and potential for long-term success.Learn about Protalix BioTherapeutics' future growth trajectory here.Overview: Nerdy, Inc. operates a platform for live online learning in the United States with a market cap of $299.21 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/protalix-biotherapeutics-2-other-promising-110503762.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CANG","PLX","SB","TUYA","BK4204","BK4179","BK4509","BK4505","BK4023","BK4563","NRDY","BK4600","TTI","BK4021","BABB","BK4526","BK4139","BK4122","BK4214","BK4209"],"gpt_icon":0},{"id":"2521419217","title":"Protalix BioTherapeutics to Present at the iAccess Alpha Virtual Best Ideas Spring Conference 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2521419217","media":"PR Newswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521419217?lang=en_us&edition=fundamental","pubTime":"2025-03-24 18:50","pubTimestamp":1742813400,"startTime":"0","endTime":"0","summary":"CARMIEL, Israel, March 24, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. , a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx plant cell–based protein expression system, today announced that its management will be participating in the iAccess Alpha Virtual Best Ideas Spring Investment Conference 2025, to be held virtually March 25-26, 2025.iAccess Alpha hosts virtual investor conferences featuring companies recommended by investors. These two-day events include webcast presentations on Day 1, followed by one-on-one meetings between Protalix management and pre-qualified investors on Day 2.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/protalix-biotherapeutics-present-iaccess-alpha-105000503.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/protalix-biotherapeutics-present-iaccess-alpha-105000503.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2521242723","title":"Is Protalix BioTherapeutics (PLX) The High Growth Low Debt Stock to Invest in Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2521242723","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521242723?lang=en_us&edition=fundamental","pubTime":"2025-03-23 05:42","pubTimestamp":1742679754,"startTime":"0","endTime":"0","summary":"We recently published a list of 12 High Growth Low Debt Stocks to Invest in Now. In this article, we are going to take a look at where Protalix BioTherapeutics, Inc.  stands against other high growth low debt stocks to invest in now.The global financial markets are experiencing heightened volatility, influenced by a confluence of economic and geopolitical factors. The broader markethas entered correction territory, reflecting investor apprehension regarding escalating trade tensions and potential economic slowdowns.The recent imposition of tariffs by the United States has been a significant catalyst for market fluctuations. In response, major indices such as the broader market and Nasdaq Composite have experienced notable declines. This environment has led to a reassessment of investment strategies, with a growing emphasis on asset quality and financial resilience.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/protalix-biotherapeutics-plx-high-growth-214234788.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","PLX"],"gpt_icon":0},{"id":"2520709416","title":"PLX: 2024 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2520709416","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520709416?lang=en_us&edition=fundamental","pubTime":"2025-03-18 17:33","pubTimestamp":1742290380,"startTime":"0","endTime":"0","summary":"Protalix Biotherapeutics, Inc.  announced 2024 financial and operational results in a March 17th, 2024 press release and in its Form 10-K filing. The reports were followed by a conference call which discussed recent achievements, clinical updates and financial performance. In 2024, Protalix repaid its convertible debt and completed the Phase I PRX-115 trial in gout. A poster presentation in November summarized the findings at the American College of Rheumatology conference. A Phase II study for PRX-115 is now planned for 2H:25. 2024 product revenues rose 31%, driven by inventory builds of Elfabrio by Chiesi.2024 revenues essentially matched our estimates at $53.4 million were dominated by revenues from Chiesi. This produced annual net income of $2.9 million or $0.04 per share.Revenues were $53.4 million, down 18% from $65.5 million due to the recognition of a $20 million milestone related to the Elfabrio approval. Product revenues rose 31% due to a material increase in sales of Elfabri","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/plx-2024-results-093300180.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4534","BK4588","BK4208","LU0122379950.USD","IE00BD4GTT62.SGD","IE00BLSP4452.SGD","IE00BMG7P587.USD","LU1066051498.USD","BK4568","LU1894683264.USD","LU0985481810.HKD","IE00BD4GTW91.USD","IE00BBT3K403.USD","LU1057294990.SGD","IE00BMG7P694.USD","LU0225284248.USD","SG9999001176.USD","IE0002270589.USD","LU1883839398.USD","LU0225771236.USD","IE00BMG7P819.SGD","PLX","LU0868494617.USD","SG9999013999.USD","SG9999002224.SGD","BK4139","BK4585","LU0321505868.SGD","BK4533","BK4550","LU0306807586.USD","PEG","IE00B19Z3B42.SGD","IE00BLSP4239.USD","LU1023059063.AUD","IE00BMG7P926.USD","BK4592","LU0058720904.USD","LU0321505439.SGD","SG9999001176.SGD","IE000M9KFDE8.USD","LU0306806265.USD","IE00BD4GTV84.USD","BK4007","BK4599","LU1894683348.USD","SG9999003800.SGD","LU0456855351.SGD","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2520793668","title":"Protalix BioTherapeutics Reports Record Revenue and Clinical Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2520793668","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520793668?lang=en_us&edition=fundamental","pubTime":"2025-03-18 11:53","pubTimestamp":1742269999,"startTime":"0","endTime":"0","summary":"Protalix Biotherapeutics ( ($PLX) ) has released its Q4 earnings. Here is a breakdown of the information Protalix Biotherapeutics presented to its ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/protalix-biotherapeutics-reports-record-revenue-and-clinical-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/protalix-biotherapeutics-reports-record-revenue-and-clinical-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS","PLX"],"gpt_icon":0},{"id":"2520571714","title":"Protalix BioTherapeutics Says With Debt Fully Repaid, It's Well-Positioned To Execute Strategy Through 2025 And Beyond","url":"https://stock-news.laohu8.com/highlight/detail?id=2520571714","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520571714?lang=en_us&edition=fundamental","pubTime":"2025-03-17 23:56","pubTimestamp":1742226988,"startTime":"0","endTime":"0","summary":"Protalix saw record revenue growth in 2024, driven by increased sales to Chiesi, Pfizer, and Brazil. The company aims to start a Phase 2 trial for PRX-115 in 2025.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/general/health-care/25/03/44359442/protalix-biotherapeutics-says-with-debt-fully-repaid-its-well-positioned-to-execute-strategy-through-2025-and-beyond","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000M9KFDE8.USD","LU0234572021.USD","BK4139","LU1066051498.USD","LU0456855351.SGD","IE00BLSP4452.SGD","BK4592","LU0170899867.USD","PLX","SG9999003800.SGD","LU1057294990.SGD","LU1894683348.USD","LU0058720904.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","BK4599","IE0002270589.USD","LU0306807586.USD","SG9999002224.SGD","SG9999011175.SGD","IE00B19Z3581.USD","BK4533","STRK","SG9999013999.USD","BK4007","LU1894683264.USD","LU0122379950.USD","BK4178","BK4516","LU0306806265.USD","BK4534","LU1883839398.USD","LU0289739699.SGD","LU0868494617.USD","BK4600","BK4595","LU0321505439.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","BK4585","BK4581","LU0225771236.USD","BK4588","BK4568","SG9999002232.USD"],"gpt_icon":1},{"id":"2520154937","title":"Protalix BioTherapeutics FY 2024 GAAP EPS $0.04 Beats $0.01 Estimate, Sales $53.40M Miss $53.94M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2520154937","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520154937?lang=en_us&edition=fundamental","pubTime":"2025-03-17 19:00","pubTimestamp":1742209239,"startTime":"0","endTime":"0","summary":"Protalix BioTherapeutics (AMEX:PLX) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.01 by 300 percent. This is a 55.56 percent decrease over earnings of $0.09 per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44352802/protalix-biotherapeutics-fy-2024-gaap-eps-0-04-beats-0-01-estimate-sales-53-40m-miss-53-94m-estimat","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Protalix BioTherapeutics FY 2024 GAAP EPS $0.04 Beats $0.01 Estimate, Sales $53.40M Miss $53.94M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLX"],"gpt_icon":0},{"id":"2520512546","title":"Press Release: Protalix BioTherapeutics Reports Fiscal Year 2024 Financial and Business Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2520512546","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520512546?lang=en_us&edition=fundamental","pubTime":"2025-03-17 18:50","pubTimestamp":1742208600,"startTime":"0","endTime":"0","summary":"Company to host conference call and webcast today at 8:30 a.m. EDT. \"2024 was a record year in revenues from selling goods for Protalix, as we experienced increases in all three of our revenue streams, Chiesi, Pfizer and Brazil,\" said Dror Bashan, Protalix's President and Chief Executive Officer. \"We are pleased with the promising results from our first-in-human study of our gout candidate, PRX-115, in adult volunteers with elevated uric acid levels, and hope to build on this momentum with the goal of initiating a phase II clinical trial in patients with gout during the second half of 2025. At the same time, we continued to evaluate additional pipeline candidates, including PRX-119, for potential further development. Now that our debt is fully repaid and we no longer have outstanding warrants, our balance sheet is stronger and we are well-positioned to continue executing on our strategy through 2025 and beyond.\"","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0456855351.SGD","BK4022","MAA","SG9999013999.USD","IE00BLSP4239.USD","BK4581","LU0234572021.USD","LU1894683348.USD","BK4592","SG9999011175.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","BK4215","LU0306806265.USD","BK4534","LU1894683264.USD","LU0170899867.USD","IE00B19Z3581.USD","LU0225284248.USD","PLX","SG9999002224.SGD","LU0321505868.SGD","LU1023059063.AUD","SG9999001176.USD","IE00B19Z3B42.SGD","SG9999003800.SGD","LU0289739699.SGD","BK4139","BK4218","LU0868494617.USD","LU0058720904.USD","IE0002270589.USD","BK4110","LU0306807586.USD","BK4588","ACR","LU0225771236.USD","BK4232","SG9999001176.SGD","BK4599","R","LU1066053197.SGD","SG9999002232.USD","PK","LU0122379950.USD","LU1883839398.USD","LU1057294990.SGD","IE00BLSP4452.SGD"],"gpt_icon":1},{"id":"2518350244","title":"Protalix BioTherapeutics to Announce Fiscal Year 2024 Financial and Business Results on March 17, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2518350244","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518350244?lang=en_us&edition=fundamental","pubTime":"2025-03-10 18:50","pubTimestamp":1741603800,"startTime":"0","endTime":"0","summary":"Company to host conference call and webcast at 8:30 a.m. EDT. CARMIEL, Israel, March 10, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. , a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx plant cell–based protein expression system, today announced that it will release its financial results for the fiscal year ended December 31, 2024 and provide a business and clinical update on March 17, 2025.Management will host a conference call to discuss the financial results and provide an update on recent corporate and regulatory developments.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/protalix-biotherapeutics-announce-fiscal-2024-105000870.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/protalix-biotherapeutics-announce-fiscal-2024-105000870.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PLX","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":38,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PLX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-09","symbol":"PLX","fiscalQuarterEnding":"2025/03","expectedEps":0.08,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746763200000,"reportTimeType":"pre","actualEps":-0.05},{"market":"US","date":"2025-03-17","symbol":"PLX","fiscalQuarterEnding":"2024/12","expectedEps":0.07,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742184000000,"reportTimeType":"pre","actualEps":0.09},{"market":"US","date":"2024-11-14","symbol":"PLX","fiscalQuarterEnding":"2024/09","expectedEps":0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"pre","actualEps":0.03},{"market":"US","date":"2024-08-14","symbol":"PLX","fiscalQuarterEnding":"2024/06","expectedEps":0.02,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"pre","actualEps":-0.03},{"date":"2024-05-10","symbol":"PLX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/03","expectedEps":-0.02,"defaultRemindTime":1715328000000,"name":null,"time":"Pre-Market","dateTimestamp":1715313600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PLX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PLX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1738641600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PLX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PLX","date":"2025-05-09","current":76.914792,"percent":0.995122,"low":-43.274752,"twenty":-14.199078,"median":-3.62153,"eighty":10.01918,"high":81.705333,"avg":-3.206985,"sd":17.449621,"marketCap":225514170},"quantilePoints":[{"date":"2020-05-15","current":-5.236692,"twenty":-3.102952,"median":-2.159816,"eighty":-1.286168,"marketCap":95705776},{"date":"2020-05-22","current":-5.307698,"twenty":-3.102952,"median":-2.159816,"eighty":-1.286168,"marketCap":97003481},{"date":"2020-05-29","current":-5.929,"twenty":-3.102952,"median":-2.159816,"eighty":-1.286168,"marketCap":108358404},{"date":"2020-06-05","current":-12.463249,"twenty":-3.102952,"median":-2.159816,"eighty":-1.286168,"marketCap":116469063},{"date":"2020-06-12","current":-12.324383,"twenty":-3.102952,"median":-2.159816,"eighty":-1.286168,"marketCap":115171357},{"date":"2020-06-19","current":-14.511527,"twenty":-3.102952,"median":-2.159816,"eighty":-1.286168,"marketCap":135610218},{"date":"2020-06-26","current":-13.192297,"twenty":-3.102952,"median":-2.159816,"eighty":-1.286168,"marketCap":123282016},{"date":"2020-07-02","current":-12.949281,"twenty":-3.102952,"median":-2.159816,"eighty":-1.286168,"marketCap":121011032},{"date":"2020-07-10","current":-12.116083,"twenty":-3.102952,"median":-2.159816,"eighty":-1.286168,"marketCap":113224799},{"date":"2020-07-17","current":-12.602115,"twenty":-3.102952,"median":-2.159816,"eighty":-1.286168,"marketCap":117766768},{"date":"2020-07-24","current":-12.428532,"twenty":-3.102952,"median":-2.159816,"eighty":-1.286168,"marketCap":116144636},{"date":"2020-07-31","current":-12.428532,"twenty":-3.102952,"median":-2.159816,"eighty":-1.286168,"marketCap":116144636},{"date":"2020-08-07","current":-12.463249,"twenty":-3.102952,"median":-2.159816,"eighty":-1.286168,"marketCap":116469063},{"date":"2020-08-14","current":-20.925275,"twenty":-3.102952,"median":-2.159816,"eighty":-1.286168,"marketCap":120362179},{"date":"2020-08-21","current":-21.432896,"twenty":-3.102952,"median":-2.159816,"eighty":-1.286168,"marketCap":123282016},{"date":"2020-08-28","current":-20.192044,"twenty":-3.102952,"median":-2.159816,"eighty":-1.286168,"marketCap":116144636},{"date":"2020-09-04","current":-19.289606,"twenty":-3.102952,"median":-2.159816,"eighty":-1.286168,"marketCap":110953815},{"date":"2020-09-11","current":-19.063997,"twenty":-3.102952,"median":-2.159816,"eighty":-1.286168,"marketCap":109656109},{"date":"2020-09-18","current":-20.58686,"twenty":-3.102952,"median":-2.159816,"eighty":-1.286168,"marketCap":118415621},{"date":"2020-09-25","current":-20.58686,"twenty":-3.102952,"median":-2.159816,"eighty":-1.286168,"marketCap":118415621},{"date":"2020-10-02","current":-20.925275,"twenty":-3.102952,"median":-2.159816,"eighty":-1.286168,"marketCap":120362179},{"date":"2020-10-09","current":-21.320091,"twenty":-3.102952,"median":-2.159816,"eighty":-1.286168,"marketCap":122633164},{"date":"2020-10-16","current":-20.530458,"twenty":-3.102952,"median":-2.159816,"eighty":-1.286168,"marketCap":118091195},{"date":"2020-10-23","current":-19.910032,"twenty":-3.109096,"median":-2.159816,"eighty":-1.286168,"marketCap":114522505},{"date":"2020-10-30","current":-16.444568,"twenty":-3.109096,"median":-2.159816,"eighty":-1.286168,"marketCap":109011038},{"date":"2020-11-06","current":-16.243411,"twenty":-3.109096,"median":-2.159816,"eighty":-1.286168,"marketCap":107677570},{"date":"2020-11-13","current":-17.148616,"twenty":-3.133674,"median":-2.159816,"eighty":-1.286168,"marketCap":113678177},{"date":"2020-11-20","current":-19.914522,"twenty":-3.195119,"median":-2.159816,"eighty":-1.286168,"marketCap":132013367},{"date":"2020-11-27","current":-18.204689,"twenty":-3.23072,"median":-2.159816,"eighty":-1.286168,"marketCap":120678886},{"date":"2020-12-04","current":-17.136276,"twenty":-3.35334,"median":-2.159816,"eighty":-1.286168,"marketCap":113596373},{"date":"2020-12-11","current":-18.121119,"twenty":-3.873376,"median":-2.159816,"eighty":-1.286168,"marketCap":120124900},{"date":"2020-12-18","current":-17.333245,"twenty":-4.1371,"median":-2.159816,"eighty":-1.286168,"marketCap":114902078},{"date":"2020-12-24","current":-16.939307,"twenty":-4.175152,"median":-2.159816,"eighty":-1.286168,"marketCap":112290667},{"date":"2020-12-31","current":-17.874908,"twenty":-4.217317,"median":-2.159816,"eighty":-1.286168,"marketCap":118492768},{"date":"2021-01-08","current":-18.318088,"twenty":-4.444705,"median":-2.159816,"eighty":-1.286168,"marketCap":121430605},{"date":"2021-01-15","current":-20.533986,"twenty":-4.900297,"median":-2.159816,"eighty":-1.286168,"marketCap":136119792},{"date":"2021-01-22","current":-22.552915,"twenty":-5.019257,"median":-2.159816,"eighty":-1.286168,"marketCap":149503272},{"date":"2021-01-29","current":-21.568071,"twenty":-5.289946,"median":-2.159816,"eighty":-1.286168,"marketCap":142974745},{"date":"2021-02-05","current":-24.177906,"twenty":-5.314856,"median":-2.159816,"eighty":-1.286168,"marketCap":160275342},{"date":"2021-02-12","current":-32.70229,"twenty":-5.396455,"median":-2.159816,"eighty":-1.286168,"marketCap":216783482},{"date":"2021-02-19","current":-34.103817,"twenty":-5.467461,"median":-2.159816,"eighty":-1.286168,"marketCap":226074202},{"date":"2021-02-26","current":-33.545915,"twenty":-5.52745,"median":-2.159816,"eighty":-1.286168,"marketCap":222375871},{"date":"2021-03-05","current":-28.68518,"twenty":-5.574564,"median":-2.158792,"eighty":-1.286095,"marketCap":190154061},{"date":"2021-03-12","current":-33.20361,"twenty":-5.648785,"median":-2.158792,"eighty":-1.286095,"marketCap":220106730},{"date":"2021-03-19","current":-34.915136,"twenty":-5.812013,"median":-2.158792,"eighty":-1.286095,"marketCap":231452438},{"date":"2021-03-26","current":-33.066688,"twenty":-5.93244,"median":-2.159816,"eighty":-1.286168,"marketCap":219199073},{"date":"2021-04-01","current":-31.238527,"twenty":-6.011792,"median":-2.159816,"eighty":-1.286168,"marketCap":203768911},{"date":"2021-04-09","current":-36.595691,"twenty":-6.161232,"median":-2.158792,"eighty":-1.286095,"marketCap":238713691},{"date":"2021-04-16","current":-43.135605,"twenty":-6.301781,"median":-2.158792,"eighty":-1.286095,"marketCap":281373552},{"date":"2021-04-23","current":-43.274752,"twenty":-6.484124,"median":-2.158792,"eighty":-1.286095,"marketCap":282281208},{"date":"2021-04-30","current":-23.307141,"twenty":-6.640471,"median":-2.159816,"eighty":-1.286168,"marketCap":152032483},{"date":"2021-05-07","current":-21.150361,"twenty":-6.746429,"median":-2.159816,"eighty":-1.286168,"marketCap":137963806},{"date":"2021-05-14","current":-9.099814,"twenty":-6.956439,"median":-2.159816,"eighty":-1.286168,"marketCap":124348956},{"date":"2021-05-21","current":-9.664401,"twenty":-7.610873,"median":-2.159816,"eighty":-1.286168,"marketCap":132064038},{"date":"2021-05-28","current":-10.096144,"twenty":-9.073245,"median":-2.159816,"eighty":-1.286168,"marketCap":137963806},{"date":"2021-06-04","current":-7.107154,"twenty":-9.166236,"median":-2.159816,"eighty":-1.286168,"marketCap":97119258},{"date":"2021-06-11","current":-7.206787,"twenty":-9.166236,"median":-2.159816,"eighty":-1.286168,"marketCap":98480743},{"date":"2021-06-18","current":-6.6422,"twenty":-9.166236,"median":-2.159816,"eighty":-1.286168,"marketCap":90765662},{"date":"2021-06-25","current":-6.608989,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":90311833},{"date":"2021-07-02","current":-5.97798,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":81689095},{"date":"2021-07-09","current":-5.745503,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":78512297},{"date":"2021-07-16","current":-5.247338,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":71704872},{"date":"2021-07-23","current":-5.214127,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":71251044},{"date":"2021-07-30","current":-5.014861,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":68528074},{"date":"2021-08-06","current":-4.98165,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":68074246},{"date":"2021-08-13","current":-4.450274,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":60812993},{"date":"2021-08-20","current":-2.941121,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":61045906},{"date":"2021-08-27","current":-3.511786,"twenty":-9.099814,"median":-2.160476,"eighty":-1.286241,"marketCap":72890635},{"date":"2021-09-03","current":-3.533735,"twenty":-9.093172,"median":-2.165862,"eighty":-1.286241,"marketCap":73346201},{"date":"2021-09-10","current":-3.2923,"twenty":-9.093172,"median":-2.168414,"eighty":-1.286241,"marketCap":68334970},{"date":"2021-09-17","current":-3.072813,"twenty":-9.093172,"median":-2.169861,"eighty":-1.286241,"marketCap":63779305},{"date":"2021-09-24","current":-2.875275,"twenty":-9.093172,"median":-2.173457,"eighty":-1.286241,"marketCap":59679207},{"date":"2021-10-01","current":-2.743583,"twenty":-9.093172,"median":-2.185224,"eighty":-1.286241,"marketCap":56945808},{"date":"2021-10-08","current":-2.919172,"twenty":-9.08653,"median":-2.194729,"eighty":-1.286241,"marketCap":60590340},{"date":"2021-10-15","current":-2.699686,"twenty":-9.08653,"median":-2.198569,"eighty":-1.286241,"marketCap":56034675},{"date":"2021-10-22","current":-2.546045,"twenty":-9.08653,"median":-2.208245,"eighty":-1.286241,"marketCap":52845710},{"date":"2021-10-29","current":-2.480199,"twenty":-9.08653,"median":-2.213276,"eighty":-1.286241,"marketCap":51479011},{"date":"2021-11-05","current":-2.436302,"twenty":-9.08653,"median":-2.224699,"eighty":-1.286241,"marketCap":50567878},{"date":"2021-11-12","current":-2.502148,"twenty":-9.08653,"median":-2.237881,"eighty":-1.286241,"marketCap":51934577},{"date":"2021-11-19","current":-2.175919,"twenty":-9.08653,"median":-2.240695,"eighty":-1.286241,"marketCap":44645514},{"date":"2021-11-26","current":-2.198123,"twenty":-9.08653,"median":-2.240695,"eighty":-1.286241,"marketCap":45101080},{"date":"2021-12-03","current":-1.806013,"twenty":-9.08653,"median":-2.233869,"eighty":-1.286241,"marketCap":37055776},{"date":"2021-12-10","current":-2.038925,"twenty":-9.079887,"median":-2.232086,"eighty":-1.286241,"marketCap":41834668},{"date":"2021-12-17","current":-1.940121,"twenty":-9.079887,"median":-2.232086,"eighty":-1.286241,"marketCap":39807398},{"date":"2021-12-23","current":-2.10931,"twenty":-9.079887,"median":-2.232086,"eighty":-1.286241,"marketCap":43278814},{"date":"2021-12-31","current":-1.846645,"twenty":-9.079887,"median":-2.228368,"eighty":-1.286241,"marketCap":37889463},{"date":"2022-01-07","current":-1.90948,"twenty":-9.073245,"median":-2.222793,"eighty":-1.286241,"marketCap":39178716},{"date":"2022-01-14","current":-1.909036,"twenty":-9.073245,"median":-2.219151,"eighty":-1.286241,"marketCap":39169605},{"date":"2022-01-21","current":-1.809011,"twenty":-9.073245,"median":-2.213239,"eighty":-1.286241,"marketCap":37117278},{"date":"2022-01-28","current":-1.800151,"twenty":-9.073245,"median":-2.199659,"eighty":-1.286241,"marketCap":36935507},{"date":"2022-02-04","current":-2.286936,"twenty":-9.073245,"median":-2.19473,"eighty":-1.286241,"marketCap":46923346},{"date":"2022-02-11","current":-2.053801,"twenty":-9.073245,"median":-2.192317,"eighty":-1.286241,"marketCap":42139898},{"date":"2022-02-18","current":-1.900155,"twenty":-9.073245,"median":-2.182859,"eighty":-1.286241,"marketCap":38987378},{"date":"2022-02-25","current":-1.845979,"twenty":-9.073245,"median":-2.171729,"eighty":-1.286241,"marketCap":37875796},{"date":"2022-03-04","current":-1.953887,"twenty":-9.073245,"median":-2.164775,"eighty":-1.286241,"marketCap":40089849},{"date":"2022-03-11","current":-1.931683,"twenty":-9.073245,"median":-2.149114,"eighty":-1.286241,"marketCap":39634282},{"date":"2022-03-18","current":-2.331342,"twenty":-9.073245,"median":-2.134081,"eighty":-1.286241,"marketCap":47834479},{"date":"2022-03-25","current":-2.58668,"twenty":-9.073245,"median":-2.134081,"eighty":-1.286241,"marketCap":53073493},{"date":"2022-04-01","current":-1.763177,"twenty":-9.073245,"median":-2.127387,"eighty":-1.286241,"marketCap":48631935},{"date":"2022-04-08","current":-2.518824,"twenty":-9.073245,"median":-2.127387,"eighty":-1.286241,"marketCap":69474193},{"date":"2022-04-14","current":-2.199773,"twenty":-9.073245,"median":-2.127387,"eighty":-1.286241,"marketCap":60674128},{"date":"2022-04-22","current":-2.000411,"twenty":-9.073245,"median":-2.122964,"eighty":-1.286241,"marketCap":55175340},{"date":"2022-04-29","current":-1.950023,"twenty":-9.073245,"median":-2.109577,"eighty":-1.286241,"marketCap":53785525},{"date":"2022-05-06","current":-1.907996,"twenty":-9.073245,"median":-2.106167,"eighty":-1.286241,"marketCap":52626354},{"date":"2022-05-13","current":-1.781917,"twenty":-9.073245,"median":-2.101634,"eighty":-1.296523,"marketCap":49148841},{"date":"2022-05-20","current":-2.19949,"twenty":-9.073245,"median":-2.104124,"eighty":-1.305734,"marketCap":53652162},{"date":"2022-05-27","current":-2.19949,"twenty":-9.073245,"median":-2.108744,"eighty":-1.316067,"marketCap":53652162},{"date":"2022-06-03","current":-2.392428,"twenty":-9.073245,"median":-2.111908,"eighty":-1.325755,"marketCap":58358492},{"date":"2022-06-10","current":-2.160903,"twenty":-9.073245,"median":-2.122315,"eighty":-1.336668,"marketCap":52710896},{"date":"2022-06-17","current":-2.103021,"twenty":-9.073245,"median":-2.122315,"eighty":-1.340638,"marketCap":51298997},{"date":"2022-06-24","current":-2.103021,"twenty":-9.079887,"median":-2.122315,"eighty":-1.345105,"marketCap":51298997},{"date":"2022-07-01","current":-2.093374,"twenty":-9.079887,"median":-2.123693,"eighty":-1.358968,"marketCap":51063680},{"date":"2022-07-08","current":-2.141609,"twenty":-9.079887,"median":-2.128772,"eighty":-1.362564,"marketCap":52240263},{"date":"2022-07-15","current":-2.083727,"twenty":-9.079887,"median":-2.129233,"eighty":-1.365604,"marketCap":50828364},{"date":"2022-07-22","current":-2.04514,"twenty":-9.079887,"median":-2.129233,"eighty":-1.382433,"marketCap":49887098},{"date":"2022-07-29","current":-2.04514,"twenty":-9.079887,"median":-2.129233,"eighty":-1.400792,"marketCap":49887098},{"date":"2022-08-05","current":-2.122315,"twenty":-9.079887,"median":-2.129233,"eighty":-1.416087,"marketCap":51769630},{"date":"2022-08-12","current":-2.363487,"twenty":-9.079887,"median":-2.141609,"eighty":-1.428705,"marketCap":57652542},{"date":"2022-08-19","current":-3.229692,"twenty":-9.079887,"median":-2.151454,"eighty":-1.454072,"marketCap":59704090},{"date":"2022-08-26","current":-3.175864,"twenty":-9.079887,"median":-2.160903,"eighty":-1.46638,"marketCap":58709022},{"date":"2022-09-02","current":-2.933637,"twenty":-9.079887,"median":-2.168513,"eighty":-1.513357,"marketCap":54231215},{"date":"2022-09-09","current":-2.866352,"twenty":-9.079887,"median":-2.173457,"eighty":-1.552879,"marketCap":52987380},{"date":"2022-09-16","current":-3.068208,"twenty":-9.079887,"median":-2.185224,"eighty":-1.597561,"marketCap":56718886},{"date":"2022-09-23","current":-2.772152,"twenty":-9.079887,"median":-2.19473,"eighty":-1.642895,"marketCap":51246011},{"date":"2022-09-30","current":-2.802835,"twenty":-9.079887,"median":-2.19949,"eighty":-1.691667,"marketCap":51813200},{"date":"2022-10-07","current":-2.799067,"twenty":-9.079887,"median":-2.205652,"eighty":-1.708303,"marketCap":51743545},{"date":"2022-10-14","current":-2.745238,"twenty":-9.079887,"median":-2.213275,"eighty":-1.720523,"marketCap":50748477},{"date":"2022-10-21","current":-2.772152,"twenty":-9.079887,"median":-2.225261,"eighty":-1.725838,"marketCap":51246011},{"date":"2022-10-28","current":-2.772152,"twenty":-9.079887,"median":-2.240109,"eighty":-1.732273,"marketCap":51246011},{"date":"2022-11-04","current":-2.718324,"twenty":-9.079887,"median":-2.242805,"eighty":-1.755663,"marketCap":50250943},{"date":"2022-11-11","current":-2.825981,"twenty":-9.079887,"median":-2.250369,"eighty":-1.765675,"marketCap":52241079},{"date":"2022-11-18","current":-3.036417,"twenty":-9.079887,"median":-2.262195,"eighty":-1.778799,"marketCap":54212189},{"date":"2022-11-25","current":-3.391139,"twenty":-9.079887,"median":-2.26358,"eighty":-1.789218,"marketCap":60545389},{"date":"2022-12-02","current":-3.206683,"twenty":-9.079887,"median":-2.278354,"eighty":-1.795365,"marketCap":57252125},{"date":"2022-12-09","current":-3.320194,"twenty":-9.079887,"median":-2.292748,"eighty":-1.799662,"marketCap":59278749},{"date":"2022-12-16","current":-3.291817,"twenty":-9.079887,"median":-2.300018,"eighty":-1.807377,"marketCap":58772093},{"date":"2022-12-23","current":-3.348572,"twenty":-9.079887,"median":-2.308362,"eighty":-1.815181,"marketCap":59785405},{"date":"2022-12-30","current":-3.887749,"twenty":-9.079887,"median":-2.330304,"eighty":-1.816065,"marketCap":69411869},{"date":"2023-01-06","current":-4.341793,"twenty":-9.079887,"median":-2.331425,"eighty":-1.819992,"marketCap":77518364},{"date":"2023-01-13","current":-4.597192,"twenty":-9.079887,"median":-2.347715,"eighty":-1.827125,"marketCap":82078268},{"date":"2023-01-20","current":-4.739081,"twenty":-9.079887,"median":-2.35453,"eighty":-1.836965,"marketCap":84611548},{"date":"2023-01-27","current":-4.455303,"twenty":-9.079887,"median":-2.366765,"eighty":-1.846672,"marketCap":79544988},{"date":"2023-02-03","current":-4.597192,"twenty":-9.079887,"median":-2.372929,"eighty":-1.855292,"marketCap":82078268},{"date":"2023-02-10","current":-4.483681,"twenty":-9.079887,"median":-2.377975,"eighty":-1.863262,"marketCap":80051644},{"date":"2023-02-17","current":-4.426926,"twenty":-9.079887,"median":-2.386937,"eighty":-1.865474,"marketCap":79038332},{"date":"2023-02-24","current":-5.164747,"twenty":-9.079887,"median":-2.395361,"eighty":-1.8693,"marketCap":92211388},{"date":"2023-03-03","current":-7.880419,"twenty":-9.079887,"median":-2.409349,"eighty":-1.87939,"marketCap":117631009},{"date":"2023-03-10","current":-7.111597,"twenty":-9.079887,"median":-2.414353,"eighty":-1.887277,"marketCap":106154813},{"date":"2023-03-17","current":-7.803536,"twenty":-9.079887,"median":-2.420155,"eighty":-1.897474,"marketCap":116483389},{"date":"2023-03-24","current":-7.649772,"twenty":-9.079887,"median":-2.433443,"eighty":-1.901141,"marketCap":114188150},{"date":"2023-03-31","current":-8.072624,"twenty":-9.073245,"median":-2.439918,"eighty":-1.90865,"marketCap":120500058},{"date":"2023-04-06","current":-8.226388,"twenty":-9.073245,"median":-2.446146,"eighty":-1.912148,"marketCap":122795297},{"date":"2023-04-14","current":-9.571826,"twenty":-9.400542,"median":-2.46771,"eighty":-1.922938,"marketCap":142878640},{"date":"2023-04-21","current":-8.956768,"twenty":-9.457132,"median":-2.480199,"eighty":-1.931683,"marketCap":133697683},{"date":"2023-04-28","current":-10.263765,"twenty":-9.567591,"median":-2.502031,"eighty":-1.934828,"marketCap":153207216},{"date":"2023-05-05","current":-14.724601,"twenty":-9.651117,"median":-2.520118,"eighty":-1.939455,"marketCap":219794121},{"date":"2023-05-12","current":-10.576213,"twenty":-10.196717,"median":-2.536056,"eighty":-1.94368,"marketCap":166808038},{"date":"2023-05-19","current":-9.162809,"twenty":-10.196717,"median":-2.545576,"eighty":-1.945022,"marketCap":144515819},{"date":"2023-05-26","current":-8.948724,"twenty":-10.196717,"median":-2.560684,"eighty":-1.945022,"marketCap":141139282},{"date":"2023-06-02","current":-9.162809,"twenty":-10.196717,"median":-2.582062,"eighty":-1.945022,"marketCap":144515819},{"date":"2023-06-09","current":-9.976329,"twenty":-10.332959,"median":-2.61351,"eighty":-1.945022,"marketCap":157346663},{"date":"2023-06-16","current":-9.633794,"twenty":-10.332959,"median":-2.630673,"eighty":-1.945022,"marketCap":151944203},{"date":"2023-06-23","current":-9.505344,"twenty":-10.356023,"median":-2.656774,"eighty":-1.945022,"marketCap":149918280},{"date":"2023-06-30","current":-9.291259,"twenty":-10.379088,"median":-2.691448,"eighty":-1.945022,"marketCap":146541742},{"date":"2023-07-07","current":-7.664219,"twenty":-10.379088,"median":-2.708789,"eighty":-1.945022,"marketCap":120880055},{"date":"2023-07-14","current":-7.664219,"twenty":-10.379088,"median":-2.729688,"eighty":-1.945022,"marketCap":120880055},{"date":"2023-07-21","current":-7.364501,"twenty":-10.379088,"median":-2.745103,"eighty":-1.945022,"marketCap":116152902},{"date":"2023-07-28","current":-7.150416,"twenty":-10.379088,"median":-2.745238,"eighty":-1.945022,"marketCap":112776364},{"date":"2023-08-04","current":-7.364501,"twenty":-10.38417,"median":-2.755336,"eighty":-1.944575,"marketCap":116152902},{"date":"2023-08-11","current":15.199151,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":135287640},{"date":"2023-08-18","current":15.359988,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":136719255},{"date":"2023-08-25","current":16.244595,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":144593139},{"date":"2023-09-01","current":15.199151,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":135287640},{"date":"2023-09-08","current":14.797057,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":131708602},{"date":"2023-09-15","current":13.91245,"twenty":-10.38417,"median":-2.755336,"eighty":-1.94037,"marketCap":123834718},{"date":"2023-09-22","current":13.349518,"twenty":-10.38417,"median":-2.755336,"eighty":-1.937003,"marketCap":118824064},{"date":"2023-09-29","current":12.947425,"twenty":-10.38417,"median":-2.755336,"eighty":-1.931683,"marketCap":115245026},{"date":"2023-10-06","current":12.867006,"twenty":-10.38417,"median":-2.74793,"eighty":-1.924528,"marketCap":114529219},{"date":"2023-10-13","current":11.982399,"twenty":-10.38417,"median":-2.74793,"eighty":-1.91452,"marketCap":106655335},{"date":"2023-10-20","current":11.741143,"twenty":-10.38417,"median":-2.74793,"eighty":-1.909391,"marketCap":104507912},{"date":"2023-10-27","current":11.982399,"twenty":-10.399416,"median":-2.764616,"eighty":-1.90816,"marketCap":106655335},{"date":"2023-11-03","current":13.590775,"twenty":-10.399416,"median":-2.764616,"eighty":-1.90816,"marketCap":120971487},{"date":"2023-11-10","current":9.551945,"twenty":-10.399416,"median":-2.764616,"eighty":-1.899704,"marketCap":101403452},{"date":"2023-11-17","current":9.551945,"twenty":-10.399416,"median":-2.764616,"eighty":-1.899275,"marketCap":101403452},{"date":"2023-11-24","current":9.826821,"twenty":-10.399416,"median":-2.764616,"eighty":-1.899275,"marketCap":104321537},{"date":"2023-12-01","current":10.376574,"twenty":-10.399416,"median":-2.764616,"eighty":-1.899275,"marketCap":110157707},{"date":"2023-12-08","current":11.682235,"twenty":-10.394334,"median":-2.758695,"eighty":-1.898511,"marketCap":124018610},{"date":"2023-12-15","current":12.09455,"twenty":-10.394334,"median":-2.758695,"eighty":-1.898511,"marketCap":128395738},{"date":"2023-12-22","current":11.957111,"twenty":-10.394334,"median":-2.758695,"eighty":-1.898511,"marketCap":126936695},{"date":"2023-12-29","current":12.369426,"twenty":-10.399416,"median":-2.764616,"eighty":-1.899275,"marketCap":131313823},{"date":"2024-01-05","current":11.957111,"twenty":-10.404498,"median":-2.770538,"eighty":-1.89955,"marketCap":126936695},{"date":"2024-01-12","current":11.269921,"twenty":-10.404498,"median":-2.770538,"eighty":-1.89955,"marketCap":119641483},{"date":"2024-01-19","current":10.101698,"twenty":-10.438841,"median":-2.771211,"eighty":-1.899583,"marketCap":107239622},{"date":"2024-01-26","current":10.376574,"twenty":-10.404498,"median":-2.770538,"eighty":-1.898048,"marketCap":110157707},{"date":"2024-02-02","current":10.101698,"twenty":-10.404498,"median":-2.770538,"eighty":-1.887499,"marketCap":107239622},{"date":"2024-02-09","current":10.307855,"twenty":-10.404498,"median":-2.770538,"eighty":-1.878194,"marketCap":109428186},{"date":"2024-02-16","current":10.445293,"twenty":-10.404498,"median":-2.770538,"eighty":-1.865074,"marketCap":110887228},{"date":"2024-02-23","current":9.826821,"twenty":-10.404498,"median":-2.770538,"eighty":-1.859242,"marketCap":104321537},{"date":"2024-03-01","current":11.201202,"twenty":-10.399416,"median":-2.764616,"eighty":-1.84065,"marketCap":118911962},{"date":"2024-03-08","current":10.032979,"twenty":-10.399416,"median":-2.764616,"eighty":-1.815126,"marketCap":106510101},{"date":"2024-03-15","current":12.024111,"twenty":-10.399416,"median":-2.764616,"eighty":-1.798801,"marketCap":99944409},{"date":"2024-03-22","current":11.601155,"twenty":-10.399416,"median":-2.753312,"eighty":-1.765715,"marketCap":96428803},{"date":"2024-03-28","current":10.985943,"twenty":-10.399416,"median":-2.753312,"eighty":-1.731141,"marketCap":91315155},{"date":"2024-04-05","current":10.634392,"twenty":-10.404498,"median":-2.758695,"eighty":-1.704982,"marketCap":88393070},{"date":"2024-04-12","current":10.72228,"twenty":-10.404498,"median":-2.758695,"eighty":-1.630901,"marketCap":89123591},{"date":"2024-04-19","current":9.931292,"twenty":-10.404498,"median":-2.758695,"eighty":-1.553621,"marketCap":82548900},{"date":"2024-04-26","current":10.37073,"twenty":-10.399416,"median":-2.753312,"eighty":-1.502768,"marketCap":86201506},{"date":"2024-05-03","current":10.231792,"twenty":-10.399416,"median":-2.753312,"eighty":-1.45681,"marketCap":85046657},{"date":"2024-05-10","current":11.025638,"twenty":-10.399416,"median":-2.753312,"eighty":-1.426977,"marketCap":91645105},{"date":"2024-05-17","current":12.526258,"twenty":-10.399416,"median":-2.753312,"eighty":-1.393687,"marketCap":85779818},{"date":"2024-05-24","current":12.633321,"twenty":-10.399416,"median":-2.753312,"eighty":-1.35988,"marketCap":86512979},{"date":"2024-05-31","current":12.205072,"twenty":-10.399416,"median":-2.753312,"eighty":-1.337474,"marketCap":83580335},{"date":"2024-06-07","current":12.09801,"twenty":-10.399416,"median":-2.746584,"eighty":-1.32008,"marketCap":82847174},{"date":"2024-06-14","current":12.419196,"twenty":-10.404498,"median":-2.745238,"eighty":-1.307985,"marketCap":85046657},{"date":"2024-06-21","current":12.526258,"twenty":-10.438841,"median":-2.746584,"eighty":-1.281516,"marketCap":85779818},{"date":"2024-06-28","current":13.811003,"twenty":-10.54187,"median":-2.758695,"eighty":-1.257877,"marketCap":94577748},{"date":"2024-07-05","current":11.134452,"twenty":-10.54187,"median":-2.758695,"eighty":-1.2431,"marketCap":76248727},{"date":"2024-07-12","current":12.205072,"twenty":-10.54187,"median":-2.758695,"eighty":-1.222499,"marketCap":83580335},{"date":"2024-07-15","current":12.205072,"twenty":-10.54187,"median":-2.758695,"eighty":-1.212089,"marketCap":83580335},{"date":"2024-08-02","current":11.348576,"twenty":-11.649165,"median":-2.772152,"eighty":-1.193601,"marketCap":77715049},{"date":"2024-08-09","current":11.134452,"twenty":-11.649165,"median":-2.772152,"eighty":-1.178742,"marketCap":76248727},{"date":"2024-08-16","current":-4.754699,"twenty":-11.649165,"median":-2.772152,"eighty":-1.164919,"marketCap":69865540},{"date":"2024-08-23","current":-4.697142,"twenty":-11.649165,"median":-2.793651,"eighty":-1.164919,"marketCap":69019799},{"date":"2024-08-30","current":-4.555001,"twenty":-11.649165,"median":-2.799067,"eighty":-1.164919,"marketCap":66931187},{"date":"2024-09-06","current":-5.105045,"twenty":-11.649165,"median":-2.825981,"eighty":-1.172176,"marketCap":75013527},{"date":"2024-09-13","current":-5.305243,"twenty":-11.649165,"median":-2.832709,"eighty":-1.172176,"marketCap":77955234},{"date":"2024-09-20","current":-5.755688,"twenty":-11.649165,"median":-2.864199,"eighty":-1.172176,"marketCap":84574075},{"date":"2024-09-27","current":-5.355292,"twenty":-11.649165,"median":-2.877542,"eighty":-1.183349,"marketCap":78690661},{"date":"2024-10-04","current":-5.054995,"twenty":-11.649165,"median":-2.919172,"eighty":-1.235399,"marketCap":74278100},{"date":"2024-10-11","current":-5.004946,"twenty":-11.649165,"median":-2.926909,"eighty":-1.318237,"marketCap":73542674},{"date":"2024-10-18","current":-5.455391,"twenty":-11.649165,"median":-2.961811,"eighty":-1.343261,"marketCap":80161514},{"date":"2024-10-25","current":-5.155094,"twenty":-11.649165,"median":-3.006085,"eighty":-1.359997,"marketCap":75748954},{"date":"2024-10-31","current":-5.855787,"twenty":-11.649165,"median":-3.008039,"eighty":-1.398056,"marketCap":86044928},{"date":"2024-11-08","current":-5.805737,"twenty":-11.689082,"median":-3.036417,"eighty":-1.525183,"marketCap":85309501},{"date":"2024-11-15","current":-7.056974,"twenty":-11.689082,"median":-3.072813,"eighty":-1.58483,"marketCap":103695170},{"date":"2024-11-22","current":-12.724521,"twenty":-11.98416,"median":-3.14895,"eighty":-1.643965,"marketCap":122231747},{"date":"2024-11-29","current":-13.184443,"twenty":-12.17163,"median":-3.149928,"eighty":-1.708859,"marketCap":126649762},{"date":"2024-12-06","current":-12.49456,"twenty":-12.366043,"median":-3.229692,"eighty":-1.708859,"marketCap":120022740},{"date":"2024-12-13","current":-13.797673,"twenty":-12.463249,"median":-3.291817,"eighty":-1.71628,"marketCap":132540449},{"date":"2024-12-20","current":-13.337751,"twenty":-12.497966,"median":-3.310435,"eighty":-1.73821,"marketCap":128122434},{"date":"2024-12-27","current":-13.644366,"twenty":-12.532682,"median":-3.320194,"eighty":-1.780748,"marketCap":131067777},{"date":"2025-01-03","current":-15.100787,"twenty":-12.605949,"median":-3.348572,"eighty":-1.788536,"marketCap":145058158},{"date":"2025-01-10","current":-17.400399,"twenty":-12.708302,"median":-3.419516,"eighty":-1.785226,"marketCap":167148233},{"date":"2025-01-17","current":-16.633862,"twenty":-12.808567,"median":-3.52276,"eighty":-1.785226,"marketCap":159784875},{"date":"2025-01-24","current":-19.393396,"twenty":-12.953442,"median":-3.648888,"eighty":-1.785226,"marketCap":186292964},{"date":"2025-01-31","current":-18.24359,"twenty":-13.053431,"median":-3.807696,"eighty":-1.785226,"marketCap":175247927},{"date":"2025-02-07","current":-20.619856,"twenty":-13.179071,"median":-3.887749,"eighty":-1.785226,"marketCap":198074338},{"date":"2025-02-14","current":-20.389895,"twenty":-13.360254,"median":-4.058015,"eighty":-1.785226,"marketCap":195865330},{"date":"2025-02-21","current":-18.626859,"twenty":-13.491058,"median":-4.162726,"eighty":-1.785226,"marketCap":178929606},{"date":"2025-02-28","current":-17.860321,"twenty":-13.571831,"median":-4.258509,"eighty":-1.785226,"marketCap":171566248},{"date":"2025-03-07","current":-18.166936,"twenty":-13.797673,"median":-4.37017,"eighty":-1.781917,"marketCap":174511591},{"date":"2025-03-14","current":-16.633862,"twenty":-14.027634,"median":-4.426926,"eighty":-1.806013,"marketCap":159784875},{"date":"2025-03-21","current":62.809311,"twenty":-14.199078,"median":-4.426926,"eighty":-1.781917,"marketCap":184156900},{"date":"2025-03-28","current":68.664416,"twenty":-14.199078,"median":-4.426926,"eighty":-1.731486,"marketCap":201324069},{"date":"2025-04-04","current":69.196699,"twenty":-14.199078,"median":-4.426926,"eighty":9.414507,"marketCap":202884721},{"date":"2025-04-11","current":61.478605,"twenty":-14.164789,"median":-4.426926,"eighty":9.60692,"marketCap":180255271},{"date":"2025-04-17","current":69.196699,"twenty":-14.164789,"median":-4.37017,"eighty":9.758102,"marketCap":202884721},{"date":"2025-04-25","current":78.245498,"twenty":-14.199078,"median":-4.058015,"eighty":9.826821,"marketCap":229415799},{"date":"2025-05-02","current":79.842345,"twenty":-14.199078,"median":-3.731273,"eighty":9.895541,"marketCap":234097755},{"date":"2025-05-09","current":76.914792,"twenty":-14.199078,"median":-3.62153,"eighty":10.01918,"marketCap":225514170}],"updateTime":1746920528576}}}